-49.3 (c 1, CHCl3). 1H NMR (500 MHz, CDCl3): δ 1.32 (s, 3H),
1.36 (s, 3H), 1.54 (s, 3H), 3.34 (s, 3H), 3.31-3.40 (m, 4H),
3.60-3.62 (m, 1H), 3.66-3.71 (m, 2H), 3.96 (t, J ) 10.2 Hz, 1H),
4.08 (d, J ) 5.5 Hz, 1H), 4.15-4.18 (m, 2H), 4.22 (d, J ) 3.5 Hz,
1H), 4.28 (dd, J ) 10.5 Hz, J ) 5 Hz, 1H), 4.76-4.79 (m, 2H),
4.81 (s, 1H), 4.85-4.87 (m, 2H), 5.05 (s, 1H), 5.61 (s, 1H),
7.22-7.26 (m, 3H), 7.34-7.41 (m, 5H), 7.49-7.52 (m, 4H), 7.56
(d, J ) 8.5 Hz, 2H). 13C NMR (125 MHz, CDCl3): δ 17.7, 26.4,
27.8, 54.9, 60.6, 64.0, 67.6, 68.6, 72.5, 76.0, 76.1, 77.4, 77.9, 78.3,
78.7, 84.9, 88.4, 97.8, 99.9 (JC-H ) 158.7 Hz), 101.4, 109.5, 125.2,
125.3, 126.0, 126.7, 127.5, 128.2, 128.3, 128.9, 132.1, 137.5, 138.3.
19F-NMR (471 MHz, CDCl3): δ -64.38. ESI-HRMS calcd for
C40H43F3O10Na [M + Na]+ 763.2706, found 763.2672.
Experimental Section
General Procedure for Coupling of Mannosyl Donor 8
with Acceptors. To a stirred solution of donor 8 (0.10 g, 0.16 mmol,
1 equiv), BSP (1.5 equiv), TTBP (2 equiv), and 4 Å molecular
sieves in 3.2 mL (0.05 M) of dichloromethane at -70 °C under an
Ar atmosphere was added Tf2O (1.1 equiv) slowly. The resulting
yellow mixture was stirred at this temperature for 30 min, and then
a solution of acceptor (2.0 equiv) in dichloromethane 2 mL was
added. The stirring was continued for another 30 min, and the
reaction mixture was poured into saturated aqueous NaHCO3
solution. The crude product was extracted with dichloromethane
(3 × 4 mL). The organic layer was separated, dried (MgSO4), and
concentrated. The residue was purified by column chromatography
(hexane/ethyl acetate) on silica gel to give the coupled products.
1-Adamantanyl 4,6-O-benzylidene-2-O-[3-(4-trifluorometh-
ylphenyl)-prop-2-ynyl]-3-O-benzyl-ꢀ-D-mannopyranoside (9). Vis-
cous oil. [R]25D -37.5 (c 1, CHCl3). 1H NMR (500 MHz, CDCl3):
δ 1.58-1.67 (m, 6H), 1.78-1.87 (m, 6H), 2.26 (s, 3H), 3.32-3.37
(m, 1H), 3.68 (dd, J ) 10 Hz, J ) 3.2 Hz, 1H), 3.93 (t, J ) 8.1
Hz, 1H), 4.07 (d, J ) 2.5 Hz, 1H), 4.16 (t, J ) 9.7 Hz, 1H), 4.28
(dd, J ) 10 Hz, J ) 4.7 Hz, 1H), 4.80-4.92 (m, 5H), 5.61 (s, 1H),
7.23 (m, 4H), 7.38 (m, 5H), 7.53 (m, 5H). 13C NMR (125 MHz,
CDCl3): δ 30.6, 36.2, 42.4, 60.8, 67.2, 68.8, 72.5, 75.5, 76.9, 78.5,
84.8, 88.7, 94.7, 101.4 (JC-H ) 161.3 Hz), 125.2, 126.1, 126.8,
127.5, 128.3, 128.4, 128.9, 132.1, 137.7, 138.4. 19F-NMR (471
MHz, CDCl3): δ -64.33. ESI-HRMS calcd for C40H41F3O6Na [M
+ Na]+ 697.2753, found 697.2749.
1,6-Anhydro-4-O-{4,6-O-benzylidene-2-O-[3-(4-trifluorometh-
ylphenyl)-prop-2-ynyl]-3-O-benzyl-ꢀ-D-mannopyranosyl}-2,3-
O-isopropylidene-ꢀ-D-mannopyranose (13). Viscous oil. [R]15
D
1
-68.5 (c 0.9, CHCl3); H NMR (500 MHz, CDCl3): δ 1.30 (s,
3H), 1.53 (s, 3H), 3.34-3.39 (m, 1H), 3.68 (dd, J ) 10 Hz, J ) 3
Hz, 1H), 3.77 (t, J ) 7 Hz, 1H), 3.94 (t, J ) 10 Hz, 1H), 3.98 (d,
J ) 7 Hz, 1H), 4.02 (dd, J ) 6 Hz, J ) 3 Hz, 1H), 4.09 (s, 1H),
4.20 (t, J ) 9.5 Hz, 1H), 4.25 (d, J ) 3 Hz, 1H), 4.32 (d, J ) 10.5
Hz, J ) 5 Hz, 1H), 4.37 (d, J ) 6 Hz, 1H), 4.59 (d, J ) 6 Hz, 1H),
4.77-4.89 (m, 5H), 5.33 (d, J ) 2.5 Hz, 1H), 5.62 (s, 1H),
7.23-7.26 (m, 4H), 7.33 -7.41 (m, 5H), 7.49-7.57 (m, 5H); 13
C
NMR (125 MHz, CDCl3): δ 25.9, 26.0, 61.0, 64.3, 67.7, 68.4, 72.1,
72.4, 72.8, 74.9, 75.3, 76.1, 78.4, 85.1, 88.0, 99.5, 99.9 (JC-H
)
157.3 Hz), 110.0, 125.2, 125.3, 126.0, 126.6, 127.6, 128.3, 128.4,
129.0, 132.1, 137.3, 138.0; 19F-NMR (471 MHz, CDCl3): δ -64.39;
ESI-HRMS calcd for C39H39F3O10Na [M + Na]+ 747.2393, found
747.2373.
Methyl 2,3,6-Tri-O-benzyl-4-O-[4,6-O-benzylidene-2-O-[3-(4-
trifluoromethylphenyl)-prop-2-ynyl]-3-O-benzyl-ꢀ-D-mannopy-
ranosyl]-r-D-glucopyranoside (10). Viscous oil. [R]14 -13.4 (c
D
3-O-[4,6-O-Benzylidene-2-O-[3-(4-trifluoromethylphenyl)-
prop-2-ynyl]-3-O-benzyl-ꢀ-D-mannopyranosyl]-1,2:5,6-di-O-iso-
1
0.5, CHCl3). H NMR (500 MHz, CDCl3): δ 3.02-3.07 (m, 1H),
propylidene-r-D-glucofuranose (14). Viscous oil. [R]23 -18.8
3.35 (s, 3H), 3.38-3.40 (m, 1H), 3.50-3.56 (m, 2H), 3.60 (d, J )
9 Hz, 1H), 3.67-3.77 (m, 2H), 3.86-3.89 (m, 2H), 3.92-3.96 (m,
1H), 4.03-4.07 (m, 2H), 4.35 (d, J ) 12 Hz,1H), 4.45 (s, 1H),
4.63-4.68 (m, 3H), 4.72 (d, J ) 7 Hz, 2H), 4.79-4.83 (m, 3H),
5.05 (d, J ) 10.5 Hz, 1H), 5.52 (s, 1H), 7.24-7.27 (m, 6H),
7.30-7.37 (m, 8H), 7.40-7.41 (m, 4H), 7.43-7.44 (m, 5H), 7.48
(dd, J ) 8 Hz, J ) 1.5 Hz, 3H), 7.52 (d, J ) 8 Hz, 2H). 13C NMR
(125 MHz, CDCl3): δ 55.4, 60.6, 67.2, 68.5, 68.6, 69.6, 72.7, 73.6,
D
(c 1.2, CHCl3). 1H NMR (500 MHz, CDCl3): δ 1.25 (s, 3H), 1.37
(s, 3H), 1.44 (s, 3H), 1.49 (s, 3H), 3.33 (m, 1H), 3.68 (d, J ) 8
Hz, 1H), 3.92 (t, J ) 10.2 Hz, 1H), 4.09 (d, J ) 8.5 Hz, 1H),
4.16-4.18 (m, 2H), 4.21-4.22 (m, 2H), 4.31-4.32 (m, 2H),
4.37-4.40 (m, 2H), 4.50 (s, 1H), 4.62 (s, 1H), 4.71-4.79 (m, 3H),
4.90 (d, J ) 12.5 Hz, 1H), 5.62 (s, 1H), 5.85 (s, 1H), 7.25-7.27
(m, 3H), 7.35-7.38 (m, 5H), 7.48-7.49 (m, 2H), 7.55-7.56 (m,
4H). 13C NMR (125 MHz, CDCl3): δ 25.6, 26.2, 26.5, 26.7, 60.6,
66.0, 67.7, 68.4, 73.0, 73.5, 75.8, 77.8, 78.6, 80.3, 80.6, 82.6, 85.3,
87.9, 99.5 (JC-H ) 155.0 Hz), 101.5, 104.9, 108.5, 111.9, 125.3,
126.0, 126.5, 127.6, 127.8, 128.3, 128.4, 129.0, 132.1, 137.4, 138.1.
19F-NMR (471 MHz, CDCl3): δ -64.47. ESI-HRMS calcd for
C42H45F3O11Na [M + Na]+ 805.2812, found 805.2806.
75.3, 76.4, 77.7, 78.6, 79.1, 80.2, 88.4, 98.4, 101.3, 101.4 (JC-H
)
158.8 Hz), 125.2, 126.1, 127.3, 127.4, 127.6, 127.8, 127.9, 128.1,
128.2, 128.24, 128.3, 128.6, 128.9, 132.0, 137.5, 137.6, 138.3,
138.5, 139.3. 19F-NMR (471 MHz, CDCl3): δ -64.40. ESI-HRMS
calcd for C58H57F3O11Na [M + Na]+ 1009.3751, found 1009.3744.
Methyl 2,3,6-Tri-O-benzyl-6-O-[4,6-O-benzylidene-2-O-[3-(4-
trifluoromethylphenyl)-prop-2-ynyl]-3-O-benzyl-ꢀ-D-mannopy-
6-O-[4,6-O-Benzylidene-2-O-[3-(4-trifluoromethylphenyl)-
prop-2-ynyl]-3-O-benzyl-ꢀ-D-mannopyranosyl]-1,2:3,4-di-O-iso-
propylidene-r-D-galactopyranose (15). Viscous oil. [R]15D -76.2
ranosyl]-r-D-glucopyranoside (11). Viscous oil. [R]14 -6.0 (c
D
1
0.7, CHCl3). H NMR (500 MHz, CDCl3): δ 3.20-3.25 (m, 1H),
1
3.34 (s, 3H), 3.47-3.50 (m, 3H), 3.54 (dd, J ) 9.7 Hz, J ) 3.5
Hz, 1H), 3.78 (m, 1H), 3.90 (t, J ) 10.5 Hz, 1H), 4.01 (t, J ) 9
Hz, 1H), 4.05-4.14 (m, 4H), 4.27 (dd, J ) 9.7 Hz, J ) 4.5 Hz,
1H), 4.55 (d, J ) 3.5 Hz, 1H), 4.59 (d, J ) 11.7 Hz, 1H), 4.65 (d,
J ) 11.7 Hz, 1H), 4.77-4.78 (m, 2H), 4.79-4.83 (m, 4H), 4.84
(d, J ) 8.5 Hz, 1H), 4.88 (d, J ) 11.5 Hz, 1H), 5.00 (d, J ) 11
Hz, 1H), 5.58 (s, 1H), 7.21-7.23 (m, 8H), 7.39-7.33 (m, 15H),
7.43-7.45 (m, 2H), 7.49-7.52 (m, 4H). 13C NMR (125 MHz,
CDCl3): δ 55.1, 60.4, 67.4, 68.3, 68.5, 69.6, 72.5, 73.4, 74.8, 75.0,
76.1, 76.6, 77.4, 78.5, 79.9, 82.2, 85.4, 88.1, 97.9, 101.4, 102.0
(JC-H ) 157.5 Hz), 125.3, 126.0, 127.6, 127.7, 127.8, 127.9, 128.1,
128.2, 128.3, 128.4, 128.5, 128.9, 132.1, 137.5, 138.0, 138.3, 138.4,
138.6. 19F-NMR (471 MHz, CDCl3): δ -64.34. ESI-HRMS calcd
for C58H57F3O11Na [M + Na]+ 1009.3751, found 1009.3744.
Methyl 4-O-[4,6-O-Benzylidene-2-O-[3-(4-trifluoromethylphe-
nyl)-prop-2-ynyl]-3-O-benzyl-ꢀ-D-mannopyranosyl]-2,3-O-iso-
(c 1.1, CHCl3). H NMR (500 MHz, CDCl3): δ 1.32 (s, 6H), 1.4
(s, 3H), 1.50 (s, 3H), 3.33-3.35 (m, 1H), 3.63-3.69 (m, 2H), 3.92
(t, J ) 10.2 Hz, 1H), 4.05 (dd, J ) 8 Hz, J ) 2 Hz, 1H), 4.13-4.17
(m, 2H), 4.2 (dd, J ) 8 Hz, J ) 1.5 Hz, 1H), 4.28 (d, J ) 3 Hz,
1H), 4.30-4.34 (m, 2H), 4.60 (dd, J ) 8 Hz, J ) 2.5 Hz, 1H),
4.63 (s, 1H), 4.77 (d, J ) 6 Hz, 1H), 4.8 (d, J ) 2H, 1H), 4.83 (s,
1H), 4.86 (d, J ) 3.5 Hz, 1H), 7.55 (d, J ) 5 Hz, 1H), 5.6 (s, 1H),
7.18-7.22 (m, 4H), 7.30-7.33 (m, 2H), 7.36-7.40 (m, 3H),
7.48-7.51 (m, 2H), 7.53-7.56 (m, 3H). 13C NMR (125 MHz,
CDCl3): δ 24.4, 25.1, 26.0, 60.8, 67.4, 68.1, 68.5, 70.1, 70.7, 71.5,
72.6, 75.8, 78.5, 84.8, 88.5, 96.3, 101.5, 102.5 (JC-H ) 157.5 Hz),
108.8, 109.6, 125.2, 126.0, 126.8, 127.5, 127.6, 128.2, 128.3, 128.9,
132.1, 132.2, 137.5, 138.2. 19F-NMR (471 MHz, CDCl3): δ -64.38.
ESI-HRMS calcd for C42H45F3O11Na [M + Na]+ 805.2812, found
805.2787.
Methyl 2-Azido-3,6-di-O-benzyl-4-O-[4,6-O-benzylidene-2-O-
[3-(4-trifluoromethylphenyl)-prop-2-ynyl]-3-O-benzyl-ꢀ-D-man-
nopyranosyl]-r-D-glucopyranoside (16).12 To facilitate easier
separation of 16 from excess acceptor and hydrolysis product 17,
the crude mixture from the workup was acetylated under standard
propylidene-r-L-rhamnopyranoside (12). Viscous oil. [R]16
D
(10) Crich, D.; Smith, M. J. Am. Chem. Soc. 2001, 123, 9015.
(11) Crich, D.; Smith, M.; Yao, Q.; Picione, J. Synthesis 2001, 2, 323.
J. Org. Chem. Vol. 73, No. 13, 2008 5175